Carpipramine

Carpipramine

SCHEMBL7353292

NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1.O

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Carpipramine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 known ✓ P35462 9/20 0.98
▸ CHRM2 known ✓ P08172 6/20 0.98
▸ CHRM1 known ✓ P11229 6/20 0.98
▸ ADRA1A known ✓ P35348 3/20 0.98
▸ HTR1A known ✓ P08908 2/20 0.98
▸ ADRA2A known ✓ P08913 2/20 0.98
▸ SLC6A4 known ✓ P31645 2/20 0.98
▸ OPRM1 known ✓ P35372 2/20 0.98
▸ SLC6A3 known ✓ Q01959 2/20 0.98
▸ SLC6A2 known ✓ P23975 1/20 0.98
▸ DRD4 known ✓ P21917 8/20 0.47
▸ DRD2 known ✓ P14416 7/20 0.46
▸ CHRM4 known ✓ P08173 5/20 0.46
▸ CHRM5 known ✓ P08912 5/20 0.46
▸ CHRM3 known ✓ P20309 5/20 0.46
▸ ADRB2 known ✓ P07550 1/20 0.44
▸ ADRB1 known ✓ P08588 1/20 0.44
▸ ADRA1D known ✓ P25100 1/20 0.44
▸ ADRA1B known ✓ P35368 1/20 0.44
▸ HTR2A known ✓ P28223 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carpipramine SCHEMBL17747957 0.99 DRD3 (0.96) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL17747956 0.99 DRD3 (0.96) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL29356300 0.99 DRD3 (0.96) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL969082 0.99 DRD3 (0.96) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL27478838 0.99 DRD3 (1.00) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL29913255 0.99 DRD3 (1.00) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL34949 0.99 DRD3 (1.00) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL1648924 0.98 DRD3 (0.94) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL365672 0.98 DRD3 (0.98) DRD3CHRM2CHRM1ADRA1AHTR1A
Carpipramine SCHEMBL969084 0.98 DRD3 (0.98) DRD3CHRM2CHRM1ADRA1AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996001631-A1 NOVEL COMBINATION PRODUCT COMPRISING CAPRIPRAMINE AND A NEUROLEPTIC PIERRE FABRE MEDICAMENT (FR) 1996-01-25 — — WO disclosed
Send feedback